Loading...
Loading...
Exosens SAS/ADR
Exosens SAS/ADR. Spoken Alpha tracks EXOSF's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks EXOSF's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 5/10 quarters with 60% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 3 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for EXOSF.
curl https://api.spokenalpha.com/v1/companies/EXOSF| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.36 | $3.54 | -5.0% | +8.1% | +8.1% |
| Q4 FY2026 | $3.54 | $3.49 | +1.4% | +1.5% | +2.3% |
| Q3 FY2026 | $3.14 | $3.34 | -6.1% | +1.5% | +2.7% |
| Q2 FY2026 | $3.42 | $3.61 | -5.2% | -1.7% | +1.3% |
| Q1 FY2025 | $3.51 | $3.41 | +2.9% | -2.6% | -2.7% |
| Q4 FY2025 | $3.36 | $3.38 | -0.5% | +2.4% | +4.2% |
| Q3 FY2025 | $3.85 | $3.66 | +5.3% | -0.6% | -2.7% |
| Q2 FY2025 | $3.55 | $3.64 | -2.5% | -1.4% | -2.2% |
| Q1 FY2024 | $3.72 | $3.42 | +8.7% | +3.4% | +3.6% |
| Q4 FY2024 | $3.84 | $3.66 | +4.9% | +4.3% | +6.1% |